MEETINGS - Meeting on the Drug/Device Interface (UK) October 1999:
This article was originally published in Clinica
Executive Summary
The Drug/Device Interface is the subject of a meeting to be held in London on October 11. It will give an introduction to the European Union pharmaceutical and medical device legislation and address issues such as the role of the drug-device interface; the role of notified bodies for drug/device combinations; data requirements for drugs used in medical devices; and submitting data to competent authorities. Contact Management Forum in the UK for further details. Tel: +44 1483 570 099. Fax: +44 1483 536 424.
You may also be interested in...
Sanofi Skates To Where The Puck Is With Immunology
The French drugmaker has not abandoned oncology but has made it very clear that immunology and inflammation is the priority for its R&D euros.
Pipeline Watch: Five Approvals And 23 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.